Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
00%
Est. open job positions.
Loading...

Is Inhibrx Biosciences Hiring?

Inhibrx Biosciences (INBX) currently has 0 active job postings, down 100.0% over the past three months. This hiring slowdown can signal cost-cutting, restructuring, or weakening demand. Its headcount is around 110, according to LinkedIn data.

With 0 active postings, Inhibrx Biosciences trails industry peers like Amgen (1,511) and Gilead Sciences (646).

Why Hiring Trends Matter for INBX Stock

Job posting trends are one of the earliest reads on a company’s operational direction: companies often ramp hiring before revenue accelerates and pull back before earnings disappoint. AltIndex feeds Inhibrx Biosciences’s job-posting count into the INBX AI Score as one of 25+ alternative data signals, weighed alongside web traffic, sentiment, and fundamentals.

For related employment signals, see Inhibrx Biosciences’s headcount (according to LinkedIn data), and overall employee rating.

Month over Month Job Posts

Sep 2026 1
Aug 2026 1
Jul 2026 1
Get INBX alerts in real-time
The moment the job posts trend turns, sentiment flips, or insiders trade.
Try Stock Alerts Free

Inhibrx Biosciences Job Postings: Frequently Asked Questions

Inhibrx Biosciences currently has 0 active job postings, based on AltIndex’s daily count of its open LinkedIn listings. This is down 100.0% compared with three months ago.

Inhibrx Biosciences appears to be slowing hiring, with job postings down 100.0% over the past three months. Its headcount stands at 110, according to LinkedIn data.

No single signal predicts a stock on its own, but hiring is a useful leading indicator: companies tend to add roles when they expect growth and freeze them when they don’t. AltIndex combines INBX’s job-posting trend with 25+ other signals in the AI Score rather than reading any one signal in isolation.

Inhibrx Biosciences underperforms its industry peers when it comes to Job Posts, ranking dead last.

Job postings by Inhibrx Biosciences are trending down in the last couple of months. This could indicate a slowdown or an ambition to improve margins.

Sign up and get more insights on Inhibrx Biosciences.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.